DOSSIER · 13F-HR · Q2 2026

Alphabet Inc.

$99.1B in tracked AUM across 29 positions as of Q2 2026.

AI
CIK 0001652044 · last filed Jun 30, 2026
Total AUM
$99.1B
as of Q2 2026
Holdings
29
positions
Whale Score
89
89
top tier
Activity
no data
changes this Q
AI Analysis · Q2 2026

Alphabet's Q1 2026 13F is a $4.02B, 27-position corporate venture portfolio whose AUM jumped from $2.58B in Q4 2025 to $4.02B in Q1 2026 (+$1.44B, +55.8%) — a capital infusion that the manager deployed into its largest existing positions and one dramatic new opening. The headline trade is a $1.03B new position in CME Group ($1.03B, 25.6% of AUM) — a financial-markets-and-derivatives exchange that is the portfolio's single largest holding and represents Alphabet's strategic bet on the capitalization-and-clearing infrastructure that underpins both traditional finance and the crypto-and-Digital-Assets ecosystem. The second-largest increase was Planet Labs (+$355.3M, +10.4% shares, $985.2M, 24.5%) — a satellite-imaging-and-geospatial-data company that provides the mapping-and-earth-observation data layer that powers Google Maps, Google Earth, and the company's broader geo-AI products. AST SpaceMobile ($741.1M, 18.5%, essentially flat in shares, +$91.6M in value — market appreciation) — a satellite-based-cellular-connectivity name — and Revolution Medicines ($320.2M, 8.0%, -$0.5M, -1.6% shares) round out the top four. New opens — PayPay ($66.7M, Japanese payments), Ethos Technologies ($42.1M, an AI-workflow-automation name), and a small increase in Tempus AI ($70.1M, +$1.7M, +0.2%) — are exploratory. The sold positions — Dexcom (-$68.8M), GeneDx (-$3.0M), Exact Sciences (-$2.4M), Quince Therapeutics (-$0.6M), Fulcrum Therapeutics (-$0.2M), and Repligen (-$0.1M) — represent a complete liquidation of a prior healthcare-focused sleeve. At a 77.25 whaleScore on $4.02B, this is a corporate-venture portfolio whose Q1 activity signals two themes: (1) infrastructure bets on financial-markets-and-space (CME at 26%, Planet Labs at 25%) that are strategically adjacent to Alphabet's core business; and (2) a rotation out of pure-play biotech into AI-and-automation names that are closer to the company's operational focus.

The CME opening is the most strategically interpretable trade in the filing. CME Group Inc ($1.03B, 25.6%, 3.48M shares) — the world's largest financial-derivatives exchange, operating futures-and-options markets on interest rates, equities, commodities, and cryptocurrency — opened as the portfolio's largest position in a single transaction. CME is a natural strategic fit for Alphabet's cloud-and-AI ambitions: CME's markets generate enormous volumes of structured financial data that is ideal for AI training; CME's clearing-and-settlement infrastructure requires sophisticated cloud computing; and CME's move into cryptocurrency-and-digital-asset derivatives aligns with Google's broader payments-and-blockchain interest. The $1.03B opening at 25.6% of AUM is one of the largest single-position opens in this dataset and signals that Alphabet views CME as a strategic infrastructure investment — not just a financial bet, but a partnership-or-integration candidate that would give Alphabet preferential access to financial-market data and cloud-deployment relationships.

The two second-largest positions — Planet Labs ($985.2M, 24.5%, 35.2M shares, +$355.3M, +10.4%) and AST SpaceMobile ($741.1M, 18.5%, 8.9M shares, essentially flat) — form a space-and-geospatial infrastructure pair that is directly relevant to Google's core products. Planet Labs operates a constellation of Dove satellites that image the entire Earth daily at 3-5m resolution; the data feeds Google Maps, Google Earth, Google Search's visual features, and the company's climate-and-sustainability products. Alphabet's $985.2M position (raised by $355.3M in Q1) is effectively a vertically-integrated investment in the data layer that makes Google's geo-products distinctive. AST SpaceMobile ($741.1M) — a satellite-direct-to-cell connectivity company building a space-based cellular network — benefits from the same space-and-telecom infrastructure thesis but at a different layer: while Planet Labs provides the imaging data, AST provides the connectivity fabric that would allow any smartphone to reach a satellite. Both positions are strategic infrastructure bets in the space economy.

Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
SPCX
SPACE EXPLORATION TECHN CORP
$94.2B551.2M95.0%
02
PL
PLANET LABS PBC
$1.2B35.2M1.2%
03
ASTS
AST SPACEMOBILE INC
$795M8.9M0.8%
04
CME
CME GROUP INC
$769M3.5M0.8%
05
ARM
ARM HOLDINGS PLC
$695M2.0M0.7%
06
RVMD
REVOLUTION MEDICINES INC
$552M2.9M0.6%
07
FRSH
FRESHWORKS INC
$164M16.2M0.2%
08
PBLS
PARABILIS MEDICINES INC
$135M4.9M0.1%
09
TEM
TEMPUS AI INC
$90M1.6M0.1%
10
GTLB
GITLAB INC
$83M2.7M0.1%

Filing history

2026Q2Jun 30
$99.1B 2367.4%
29 positionsView →
2026Q1Mar 31
$4.0B 55.7%
27 positionsView →
2025Q4Dec 31
$2.6B 49.0%
32 positionsView →
2025Q3Sep 30
$1.7B 18.9%
25 positionsView →
2025Q2Jun 30
$2.1B 108.7%
39 positionsLocked
2025Q1Mar 31
$1.0B 40.4%
30 positionsLocked
2024Q4Dec 31
$1.7B 6.8%
44 positionsLocked
2024Q3Sep 30
$1.8B 6.7%
46 positionsLocked
2024Q2Jun 30
$2.0B 21.5%
46 positionsLocked
2024Q1Mar 31
$2.5B 16.6%
47 positionsLocked
2023Q4Dec 31
$2.2B 38.5%
48 positionsLocked
2023Q3Sep 30
$1.6B 16.3%
51 positionsLocked
Showing 12 of 51